
CHANDAN
Chandan Healthcare Limited
- IPO Status
- Closed
- Open Date
- 10 Feb 2025
- Close Date
- 12 Feb 2025
IPO Details
- Min. Investment
- ₹1,27,200
- Price Band
- ₹151 - ₹159
- Lot Size
- 800 shares
- Issue Size
- ₹107 Cr
- Face Value
- 10
- IPO Doc
- —
Schedule
- IPO open10 Feb 2025
- IPO close date12 Feb 2025
- Allotment date13 Feb 2025
- Funds unblock or debit14 Feb 2025
- Listing date17 Feb 2025
Financial Performance
- Revenue
- Profit
Stocks similar to CHANDAN
- Vijaya Diagnostic Centre Ltd
- Dr Lal Pathlabs Ltd
- Metropolis Healthcare Ltd
FAQs
Chandan Healthcare Limited IPO is a SME IPO aggregating up to ₹107 Cr, with equity shares of face value ₹10 each. The shares are proposed to be listed on NSE.
The Chandan Healthcare Limited IPO opened on 10 Feb 2025 and closed on 12 Feb 2025. IPO Period: 10 Feb 2025 – 12 Feb 2025.
The price band for the Chandan Healthcare Limited IPO is ₹151 to ₹159 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 800 shares. At the upper price band of ₹159, the minimum investment required is ₹1,27,200.
Particular Details Lot Size 800 shares Price Band ₹151 – ₹159 Minimum Investment ₹1,27,200 Here is the timeline for the Chandan Healthcare Limited IPO:
IPO Event Date IPO Opens 10 Feb 2025 IPO Closes 12 Feb 2025 UPI Mandate Deadline 12 Feb 2025, 5:00 PM Basis of Allotment 13 Feb 2025 Refund Initiation 14 Feb 2025 Shares Credited 14 Feb 2025 Listing Date 17 Feb 2025 The basis of allotment for the Chandan Healthcare Limited IPO is expected to be finalised on 13 Feb 2025. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: KFin Technologies.
The equity shares of Chandan Healthcare Limited are proposed to be listed on NSE. Proposed Listing Date: 17 Feb 2025.
The key financial performance of Chandan Healthcare Limited is:
Financial Year Revenue Profit FY24 ₹176.59 Cr ₹16.28 Cr FY25 ₹230.12 Cr ₹22.17 Cr FY26 ₹276.39 Cr ₹27.06 Cr Revenue CAGR: 25.1% | Profit CAGR: 28.9%. Figures are as disclosed in the company's offer documents.


